Acute lymphoblastic leukaemia in infants younger than 1 year is rare, and infants with the disease have worse outcomes than do older children. We initiated an international study to investigate the effects of a new hybrid treatment protocol with elements designed to treat both acute lymphoblastic leukaemia and acute myeloid leukaemia, and to identify any prognostic factors for outcome in infants. We also did a randomised trial to establish the value of a late intensification course.Journal ArticleMulticenter StudyRandomized Controlled TrialResearch Support, Non-U.S. Gov'tSCOPUS: ar.jinfo:eu-repo/semantics/publishe
Clinical features, blast cell immunophenotype, cytogenetic findings and treatment outcome were analy...
Acute lymphoblastic leukaemia occurs in both children and adults but its incidence peaks between 2 a...
This study analyzed data on 35 infants with acute myeloid leukemia (AML) who were treated with inten...
The evolution of clinical trials for infant acute lymphoblastic leukemia RS Kotecha1,2,3, NG Gottard...
Fifty-two infants with acute lymphoblastic leukemia (ALL) enrolled in the AIEOP ALL-91 and ALL-95 st...
One hundred and twenty-six infants with acute lymphoblastic leukaemia (ALL) were treated on two cons...
One hundred and twenty-six infants with acute lymphoblastic leukaemia (ALL) were treated on two cons...
lymphoblastic leukemia (ALL) were treated on three consecutive protocols. Eighteen patients with inf...
Fifty-two infants with acute lymphoblastic leukemia (ALL) enrolled in the AIEOP ALL-91 and ALL-95 st...
PURPOSE Infant acute lymphoblastic leukemia (ALL) is characterized by KMT2A (MLL) gene rearrangement...
Acute lymphoblastic leukaemia (ALL) is rare under 1 year and has a poor prognosis. Only 14 of 48 inf...
Fifty-two infants with acute lymphoblastic leukemia (ALL) enrolled in the AIEOP ALL-91 and ALL-95 st...
textabstractAcute lymphoblastic leukemia (ALL) diagnosed in the first month of life (congenital ALL)...
Objective: To analyze patients younger than 2 years with acute lymphoblastic leukemia, treated in th...
Out of 744 newly diagnosed ALL children under the age of 18 years treated according to the EORTC-CLC...
Clinical features, blast cell immunophenotype, cytogenetic findings and treatment outcome were analy...
Acute lymphoblastic leukaemia occurs in both children and adults but its incidence peaks between 2 a...
This study analyzed data on 35 infants with acute myeloid leukemia (AML) who were treated with inten...
The evolution of clinical trials for infant acute lymphoblastic leukemia RS Kotecha1,2,3, NG Gottard...
Fifty-two infants with acute lymphoblastic leukemia (ALL) enrolled in the AIEOP ALL-91 and ALL-95 st...
One hundred and twenty-six infants with acute lymphoblastic leukaemia (ALL) were treated on two cons...
One hundred and twenty-six infants with acute lymphoblastic leukaemia (ALL) were treated on two cons...
lymphoblastic leukemia (ALL) were treated on three consecutive protocols. Eighteen patients with inf...
Fifty-two infants with acute lymphoblastic leukemia (ALL) enrolled in the AIEOP ALL-91 and ALL-95 st...
PURPOSE Infant acute lymphoblastic leukemia (ALL) is characterized by KMT2A (MLL) gene rearrangement...
Acute lymphoblastic leukaemia (ALL) is rare under 1 year and has a poor prognosis. Only 14 of 48 inf...
Fifty-two infants with acute lymphoblastic leukemia (ALL) enrolled in the AIEOP ALL-91 and ALL-95 st...
textabstractAcute lymphoblastic leukemia (ALL) diagnosed in the first month of life (congenital ALL)...
Objective: To analyze patients younger than 2 years with acute lymphoblastic leukemia, treated in th...
Out of 744 newly diagnosed ALL children under the age of 18 years treated according to the EORTC-CLC...
Clinical features, blast cell immunophenotype, cytogenetic findings and treatment outcome were analy...
Acute lymphoblastic leukaemia occurs in both children and adults but its incidence peaks between 2 a...
This study analyzed data on 35 infants with acute myeloid leukemia (AML) who were treated with inten...